Peter Herrlich

4.4k total citations · 2 hit papers
12 papers, 3.7k citations indexed

About

Peter Herrlich is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Peter Herrlich has authored 12 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Peter Herrlich's work include Virus-based gene therapy research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Chemical Synthesis and Analysis (2 papers). Peter Herrlich is often cited by papers focused on Virus-based gene therapy research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Chemical Synthesis and Analysis (2 papers). Peter Herrlich collaborates with scholars based in Germany, Switzerland and United States. Peter Herrlich's co-authors include Hans J. Rahmsdorf, Helmut Ponta, Carsten Jonat, Stephan Gebel, Andrew C.B. Cato, Kun-Koo Park, W. Rudy, Helmut Ponta, Achim Wenzel and S. Matzku and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Peter Herrlich

12 papers receiving 3.6k citations

Hit Papers

A new variant of glycoprotein CD44 confers metastatic pot... 1990 2026 2002 2014 1991 1990 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
    1991 1.4k citations Ursula Günthert, Martin Hofmann‐Apitius et al. Cell profile →
  2. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
    1990 1.4k citations Carsten Jonat, Hans J. Rahmsdorf et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Herrlich Germany 10 2.1k 1.0k 875 806 598 12 3.7k
Senén Vilaró Spain 39 2.0k 0.9× 795 0.8× 739 0.8× 368 0.5× 304 0.5× 108 4.3k
M.G. Byers United States 30 2.1k 1.0× 411 0.4× 453 0.5× 732 0.9× 382 0.6× 54 3.6k
Rolf J. Craven United States 35 2.4k 1.1× 955 0.9× 930 1.1× 495 0.6× 1.3k 2.2× 58 4.0k
Ulla Engström Sweden 33 2.9k 1.3× 690 0.7× 656 0.7× 444 0.6× 202 0.3× 48 4.1k
L. Marty France 13 2.4k 1.1× 375 0.4× 552 0.6× 441 0.5× 220 0.4× 19 3.7k
Yoshiki Murakumo Japan 38 3.3k 1.6× 560 0.5× 1.1k 1.2× 432 0.5× 286 0.5× 129 4.7k
Gene Liau United States 29 2.3k 1.1× 578 0.6× 259 0.3× 472 0.6× 477 0.8× 60 3.6k
Libert H.K. Defize Netherlands 28 3.2k 1.5× 412 0.4× 1.2k 1.3× 620 0.8× 201 0.3× 46 4.2k
Chris Marshall United Kingdom 21 2.2k 1.0× 608 0.6× 999 1.1× 306 0.4× 347 0.6× 34 3.6k
Archana Sanjay United States 31 2.4k 1.1× 924 0.9× 1.0k 1.2× 282 0.3× 405 0.7× 68 3.5k

Countries citing papers authored by Peter Herrlich

Since Specialization
Citations

This map shows the geographic impact of Peter Herrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Herrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Herrlich more than expected).

Fields of papers citing papers by Peter Herrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Herrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Herrlich. The network helps show where Peter Herrlich may publish in the future.

Co-authorship network of co-authors of Peter Herrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Herrlich. A scholar is included among the top collaborators of Peter Herrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Herrlich. Peter Herrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sherman, Larry S., Jonathan P. Sleeman, Robert F. Hennigan, Peter Herrlich, & Nancy Ratner. (1999). Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro. Oncogene. 18(48). 6692–6699. 12 indexed citations
2.
Göttlicher, Martin, Stefanie Heck, & Peter Herrlich. (1998). Transcriptional cross-talk, the second mode of steroid hormone receptor action. Journal of Molecular Medicine. 76(7). 480–489. 310 indexed citations
3.
Sherman, Larry S., Derek A. Wainwright, Helmut Ponta, & Peter Herrlich. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes & Development. 12(7). 1058–1071. 130 indexed citations
4.
Hinterding, Klaus, Axel Knebel, Peter Herrlich, & Herbert Waldmann. (1998). Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 6(8). 1153–1162. 38 indexed citations
5.
Herrlich, Andreas, Henrik Daub, Axel Knebel, et al.. (1998). Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proceedings of the National Academy of Sciences. 95(15). 8985–8990. 133 indexed citations
6.
Bender, Klaus, et al.. (1997). UV-induced signal transduction. Journal of Photochemistry and Photobiology B Biology. 37(1-2). 1–17. 229 indexed citations
7.
Waldmann, Herbert, Klaus Hinterding, Peter Herrlich, Hans J. Rahmsdorf, & Axel Knebel. (1997). Selektive Inhibierung von Rezeptor‐Tyrosinkinasen mit Aeroplysinin‐Analoga. Angewandte Chemie. 109(13-14). 1553–1555. 4 indexed citations
8.
Berg, Sanne van den, Hans J. Rahmsdorf, Peter Herrlich, & Bernd Kaina. (1993). Overexpression of c-fos increases recombination frequency in human osteosarcoma cells. Carcinogenesis. 14(5). 925–928. 20 indexed citations
9.
Günthert, Ursula, Martin Hofmann‐Apitius, W. Rudy, et al.. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65(1). 13–24. 1441 indexed citations breakdown →
10.
Jonat, Carsten, Hans J. Rahmsdorf, Kun-Koo Park, et al.. (1990). Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62(6). 1189–1204. 1386 indexed citations breakdown →
11.
Ponta, Helmut, Walter H. Günzburg, Brian Salmons, Bernd Groner, & Peter Herrlich. (1985). Mouse Mammary Tumour Virus: A Proviral Gene Contributes to the Understanding of Eukaryotic Gene Expression and Mammary Tumorigenesis. Journal of General Virology. 66(5). 931–943. 18 indexed citations
12.
Ne, Hynes, U. Rahmsdorf, N. Kennedy, et al.. (1982). DNA mediated transfer and fate of a proviral gene of mouse mammary tumor virus in cultured cells.. PubMed. 85 Pt A. 159–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Senén Vilaró Breakdown of academic impact, for papers by M.G. Byers Breakdown of academic impact, for papers by Rolf J. Craven Breakdown of academic impact, for papers by Ulla Engström Breakdown of academic impact, for papers by L. Marty Breakdown of academic impact, for papers by Yoshiki Murakumo Breakdown of academic impact, for papers by Gene Liau Breakdown of academic impact, for papers by Libert H.K. Defize Breakdown of academic impact, for papers by Chris Marshall Breakdown of academic impact, for papers by Archana Sanjay
Rankless by CCL
2026